Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


HER2+ BC: Selection and Management of Neoadjuvant Therapy

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

Early-Stage HER2+ Breast Cancer: The ATEMPT Trial

Impact of the KATHERINE Trial on Early-Stage HER2+ BC

Adjuvant Strategies in Early-Stage HER2+ Breast Cancer

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

Research into the mechanisms  that promote resistance to immune checkpoint blockade therapies suggests the need for new strategies for patients with immunorefractory disease. 

Immunotherapy Research in Oncology Focuses on Resistance

Hepatocellular Carcinoma: Future Directions in Care

Perioperative Approaches to HCC Management

Optimal Sequencing of I/O Therapy in Liver Cancer

I/O Combination Strategies in Hepatocellular Carcinoma

Elevated AFP in Relapsed/Refractory Metastatic HCC

Optimal Use of Second-Line TKIs in Hepatocellular Carcinoma

Hepatocellular Carcinoma: Antiangiogenic Therapy Options

Implications for I/O Therapy in the Treatment of HCC

Liver Pathobiology's Role in Hepatocellular Carcinoma

Neoadjuvant treatment with the combination of pembrolizumab and chemotherapy extended pathological complete response rates by 13.6 percentage points compared with chemotherapy alone for patients with early triple-negative breast cancer.

Immuno-Oncology | Specialty